Latest Growth Initiatives News

Acrow Ltd reported a robust 23% revenue increase in 1H FY26, driven by its expanding Industrial Access division, even as net profit fell 22% amid Queensland market softness. The company’s strategic investments and acquisitions position it well for future growth.

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.

Nuchev Limited reported a 12% increase in revenue to $12.38 million for the half-year ended December 2025, driven by growth in core products and offshore markets. However, the company’s net loss widened to $2.34 million amid ongoing investments in marketing, product development, and international expansion.

Firebrick Pharma reports a reduced half-year loss of $1.26 million while launching its Nasodine Throat Spray in Singapore and Fiji, with regulatory approval pending in the Philippines.

Aeris Resources has reported a robust half-year performance with a 62% jump in profit, a successful $101.6 million equity raise, and a strategic divestment of North Queensland assets. The company also announced plans to acquire Peel Mining’s South Cobar Copper Project, signaling an aggressive growth trajectory.

Scentre Group reported robust 2025 results with a 4.9% rise in Funds From Operations and record customer visitation, while progressing key sustainability and growth initiatives.

XPON Technologies has posted a strong H1 FY26 turnaround with a 58% revenue increase and a return to net profitability, driven by strategic acquisitions and operational improvements.

The Agency Group Australia Ltd has reported a solid half-year performance with revenue rising 18% to $57.1 million and a 34% jump in gross commission income. The company narrowed its net loss and improved EBITDA, driven by strong sales and agent recruitment.

Pacific Current Group reported a net loss for the half-year ending December 2025, driven by significant non-cash impairments and disposals, while repaying its senior secured debt and declaring a fully franked interim dividend.

Integral Diagnostics Limited has reported a robust half-year performance, with revenues soaring 55.6% and EBITDA nearly doubling, driven by strong patient volume growth and successful integration of Capitol Health. The company also declared a fully franked interim dividend of 3.3 cents per share.

Nanosonics Limited reported a 9% revenue increase in the first half of FY26, driven by a growing installed base and recurring sales, while advancing the commercial rollout of its new CORIS endoscope reprocessing system.

hipages Group Holdings Ltd has delivered a robust half-year performance, reporting 11% revenue growth and a significant jump in net profit to A$2.75 million for the period ending December 2025. The company’s strategic pricing changes and expansion in New Zealand underpin this strong momentum.